| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.084 | 0.008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.008 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.009 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.009 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |